Get the Stockscreener App
45.10
2.00%
-0.92
After Hours:
45.08
-0.02
-0.04%
Hims Hers Health Inc stock is traded at $45.10, with a volume of 21.49M.
It is down -2.00% in the last 24 hours and down -10.48% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$46.02
Open:
$45.22
24h Volume:
21.49M
Relative Volume:
0.55
Market Cap:
$9.82B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
65.36
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
-9.76%
1M Performance:
-10.48%
6M Performance:
-22.91%
1Y Performance:
+189.47%
1-Day Range:
$44.55
$45.76
1-Week Range:
$44.55
$48.98
52-Week Range:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
45.10 | 10.40B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.72 | 361.57B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
61.29 | 149.56B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
84.26 | 68.76B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
131.33 | 44.11B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.10 | 40.68B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - PR Newswire
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire Inc.
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
GDRX stock soars 30% today: GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims - Fast Company
Hims & Hers: Navigating a Perfect Storm of Regulatory and Partnership Risks in the Telehealth Era - AInvest
Meta's reported shake-up, Hims & Hers sinks on GoodRx–Novo deal - Yahoo Finance
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers (HIMS) Drops Amid Reported Details of FTC - GlobeNewswire
Levi & Korsinsky Releases SueWallSt Podcast on Hims & Hers Health, Inc. (HIMS) Lawsuit - ACCESS Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationHIMS - Morningstar
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
Hims & Hers Health, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsHIMS - 富途牛牛
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - MarketScreener
Hims & Hers Health: Legal Storms and the Future of Shareholder Value - AInvest
HIMS DEADLINE REMINDER: Important August 25, 2025 Deadline Reminder in Hims & Hers Health, Inc. Securities Class Action Lawsuit - PR Newswire
Join Class Action to Recover Losses from Hims & Hers Health, Inc. (HIMS)Contact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. InvestorsLead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
CoreWeave, Applied Materials And Hims & Hers Are Among Top 10 Large Cap Losers Last Week (August 11-August 15): Are The Others In Your Portfolio? - Benzinga
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - FinancialContent
HIMS INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - PR Newswire
HIMS IMPORTANT DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, - GlobeNewswire
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by LPL Financial LLC - Defense World
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - GlobeNewswire
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces - GlobeNewswire
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims - Morningstar
Hims & Hers Health Shares Drop 2.36% on 24.26% Volume Decline Ranking 106th as FTC Probes and Novo Partnership Collapse Weigh - AInvest
Hims & Hers Health's Transformation Into A Precision Health Platform (NYSE:HIMS) - Seeking Alpha
Hims & Hers: Navigating the Post-GLP-1 Landscape – Can Innovation Outpace Regulation? - AInvest
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Hims & Hers HIMS Slides on FTC Probe. What’s Next? - NAI500
Precigen, Twilio, Hims & Hers - TradingView
Levi & Korsinsky Notifies Shareholders of Hims & Hers Health, Inc.(HIMS) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge - Yahoo Finance
Why Is Hims & Hers Stock Falling Friday?Hims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers Faces Scrutiny Over Subscription Cancellations - Finimize
Securities Lawsuit Alert: Hims & Hers Health, Inc. (HIMS)Contact Levi & Korsinsky Before August 25, 2025 - Stockhouse
Hims & Hers Health Under FTC Probe for Cancellation Policies - MarketScreener
Vanguard Group Inc. Has $546.05 Million Stock Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health Plunges 2.48% on $1.11 Billion Volume Ranking 67th Amid FTC Scrutiny Over Cancellation Hurdles - AInvest
GLP-1 Sector Under Scrutiny: Hims & Hers' Crisis and the Future of Investor Trust - AInvest
Hims & Hers Health under investigation by FTC over business practicesreport - Seeking Alpha
HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, - GlobeNewswire
FTC Probing Complaints About Hims’ Cancellation Practices - Bloomberg.com
US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports - Reuters
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) InvestorsLead Plaintiff Deadline on August 25, 2025 - The Globe and Mail
FTC Investigates Hims & Hers Over Subscription Cancellation Complaints - AInvest
Here’s Why Wall Street Is Cautious on Hims & Hers Health Stock (HIMS) - TipRanks
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.33%
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):